Skip to main content
Canada’s most-awarded newsroom for a reason
Enjoy unlimited digital access
$1.99
per week
for 24 weeks
Canada’s most-awarded newsroom for a reason
$1.99
per week
for 24 weeks
// //

Hls Therapeutics Inc TSX: HLS-T

Today's Change
Volume
Real-Time Last Update TSX Last Sale

Today's Trading

Day Low 14.85
Day High 15.05
Open:15.05
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

More stories below advertisement

Description
HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada and the United States.

Fundamentals

Market Capitalization, $K
Shares Outstanding, K
36-Month Beta
Earnings Per Share (TTM)
Revenue Growth YoY
Profit Margin
5-Year Avg. Revenue Growth
5-Year Avg. Profit Growth
1-Year Total Return
3-Year Total Return
5-Year Total Return
Price/Earnings (TTM)
Price/Earnings (Forward)
Trailing Annual Dividend & Yield
Forward Annual Dividend & Yield
Most Recent Dividend
Ex-Div Date
Most Recent Split
Return on Common Equity
Return-on-Assets (Before Tax)
Debt-to-Equity Ratio
Price/Book

Earnings

Corporate earnings are provided from Morningstar, including Income Statements,Balance Sheets, Cash Flow Statements, and Statement of Retained Earnings.

Analyst Research

Analyst Ratings and Earnings Estimates are provided by Zacks Investment Research.

Strong Buy

StockReports+

A premium report that provides detailed quantitative assessments of earnings, fundamentals, relative valuation, risk, price momentum and more. For subscribers only.

StockCalc

What is this stock worth in intrinsic value? View this premium StockCalc report to see this stock's valuation and how it was calculated using fundamental analysis. For subscribers only.

ValuEngine

A stock valuation and forecasting report include rating, fair value assessment, return forecasts, market ratio-based valuations and comparable analysis. Available for free with registration.

Latest Press Releases

Saladax Biomedical and HLS Therapeutics Strengthen Partnership With an Exclusive Distribution Agreement for Canada
Business Wire - Thu Nov 18, 12:28PM CST
Business Wire - PRTGAM
Thu Nov 18, 12:28PM CST
Saladax Biomedical, Inc (Saladax) is pleased to announce an exclusive distribution agreement with HLS Therapeutics Inc. (“HLS”) (TSX:HLS) to distribute five MyCare™ Psychiatry Laboratory Assays used to measure the six most commonly prescribed...
HLS Therapeutics to Host Q3 2021 Financial Results Conference Call
Canada Newswire - Thu Oct 21, 5:30AM CDT
Canada Newswire - PRTGAM
Thu Oct 21, 5:30AM CDT
TORONTO , Oct. 21, 2021 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q3 2021 financial results on Thursday, November 4, 2021 . The Company will hold a conference call that same day at 8:30 a.m. EDT to discuss its results. The call will be hosted by Mr. Gilbert Godin , Chief Executive Officer and Mr. Tim Hendrickson , Chief Financial Officer. Slides to accompany management's prepared remarks will be available to view via the webcast .
Life Sciences Company Investor Presentations Now Available for On-Demand Viewing
Globe NewsWire - Mon Dec 21, 2020
Globe NewsWire - PRTGAM
Mon Dec 21, 2020
Individual and institutional investors as well as advisors are invited to log-on to LifeSciencesInvestorForum.com to view presentations
Price History Describes more index sector components

Price Performance

Period Period Low Period High Performance
1-Month 14.50 +2.62% increase
on 12/06/21
Period Open:18.53
Price movement based on the high, low and last over the given period.
18.66 -20.26% decrease
on 11/10/21
-3.65 (-19.70%) decrease
since 11/05/21
3-Month 14.50 +2.62% increase
on 12/06/21
Period Open:18.75
Price movement based on the high, low and last over the given period.
20.52 -27.49% decrease
on 10/21/21
-3.87 (-20.64%) decrease
since 09/07/21
52-Week 14.50 +2.62% increase
on 12/06/21
Period Open:16.75
Price movement based on the high, low and last over the given period.
21.76 -31.62% decrease
on 03/17/21
-1.87 (-11.16%) decrease
since 12/07/20

More stories below advertisement

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2021.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

© 2021 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies